ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunosuppression"

  • 2022 American Transplant Congress

    Is a Single Dose of Steroids in Adult Living Donor Liver Transplant Safe? – A Cohort Analysis

    M. Nunez, C. Praglin, A. M. Torres, E. Agudelo, H. Braun, C. Huang, S. Syed, J. Roberts, G. Roll

    University of California San Francisco, San Francisco, CA

    *Purpose: Steroids increase morbidity, and steroid avoidance (SA) has been studied in deceased donor liver transplant but, little is known about SA in living donor…
  • 2022 American Transplant Congress

    PSGL-1-mTOR-TIM3 Signaling in a Murine Model of Hindlimb Transplantation

    K. Kadono1, F. Messner2, J. He2, Y. Guo2, B. Oh2, G. Brandacher2, J. Kupiec-Weglinski1

    1UCLA Medical Center, Los Angeles, CA, 2Johns Hopkins UJohns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: Peri-transplant tissue damage driven by innate-adaptive immune cascades resulting from ischemia-reperfusion injury (IRI) is a major concern in vascularized composite allotransplantation (VCA). Here, we…
  • 2022 American Transplant Congress

    Low T Cell Responsiveness in the Early Phase Of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients

    M. Cremoni1, S. Cuozzo1, E. Martinuzzi2, S. Barbosa2, N. Ben Hassen1, F. Massa3, E. Demonchy4, M. Durand5, O. Thaunat6, V. Esnault1, M. Lequintrec7, S. Caillard8, N. Glaichenhaus2, A. Sicard1

    1Service de Néphrologie, Dialyse, Transplantation rénale, Centre Hospitalier Universitaire de Nice, Nice, France, 2CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France, 3Université Côte d'Azur, Laboratoire de Physio-Médecine Moléculaire, Nice, France, 4Service d'Infectiologie, Centre Hospitalier Universitaire de Nice, Nice, France, 5Service d'Urologie, Centre Hospitalier Universitaire de Nice, Nice, France, 6Service de Transplantation rénale, Néphrologie et Immunologie clinique, Hôpital Edouard Herriot, Hospices civils de Lyon, Lyon, France, 7Service de Néphrologie, Dialyse, Transplantation rénale, Centre Hospitalier Universitaire Lapeyronie, Montpellier, France, 8Service de Néphrologie et Transplantation, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France

    *Purpose: Kidney transplant (KT) recipients are more prone to developing life-threatening forms of COVID-19 than the general population. Little is known about the immunological mechanisms…
  • 2022 American Transplant Congress

    Development of a Patient-Reported Outcome Measure of Neurological Side Effects from Immunosuppression in Kidney Transplant Recipients

    C. Hurt1, G. J. Greene1, J. Friedewald2, D. P. Ladner2, A. Waterman3, D. Cella1, D. Peipert1

    1Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Department of Surgery and J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX

    *Purpose: Though kidney transplant is the optimal treatment for most individuals with end stage kidney disease, recipients experience significant side effects associated with their required…
  • 2022 American Transplant Congress

    Impact of Immunosuppressive Medications on SARS-CoV-2 Vaccination Response in Kidney Transplant Patients

    O. Sogbein1, A. Rizvi2, M. Mujtaba3, M. Kueht4, J. Fair4, A. Gamilla-Crudo3, S. Hussain5

    1Internal Medicine, Division of Nephrology, University of Texas Medical Branch, Galveston, TX, 2Internal Medicine, Nephrology, University of Texas Medical Branch at Galveston, Galveston, TX, 3University of Texas Medical Branch, Galveston, TX, 4Surgery, University of Texas Medical Branch, Galveston, TX, 5University of Texas Medical Branch, Houston, TX

    *Purpose: The COVID-19 pandemic portends significant morbidity and mortality in immunocompromised individuals. Vaccination against COVID-19 among immunocompromised population is an essential step to minimize deadly…
  • 2022 American Transplant Congress

    Recipient and Grafts Outcomes in Simultaneous Kidney and Pancreas Transplantation with Steroid Avoidance in the United States

    A. Cerise1, A. Dinesh2, V. Humphreville2, S. Jackson3, R. Kandaswamy2, S. Riad4

    1Surgery, University of Minnesota, Minnesota, MN, 2Surgery, University of Minnesota, Minneapolis, MN, 3Analytics, MHealth-Fairview, Minneapolis, MN, 4Medicine, University of Minnesota, Eden Prairie, MN

    *Purpose: Steroid avoidance in kidney transplantation has been proven non-inferior. Data on steroid avoidance in simultaneous pancreas-kidney (SPK) is scant.*Methods: We utilized the Scientific Registry…
  • 2022 American Transplant Congress

    Use of Dd-cfdna to Guide Tapering of Immunosuppression Therapy in Kidney Transplant Recipients

    G. Osuchukwu1, A. Trevino1, L. Beretich2, S. McCormick2, N. Kaur2, R. White2, P. Gauthier2

    1Victoria Kidney and Dialysis Associates, Victoria, TX, 2Natera, Inc., Austin, TX

    *Purpose: Continuous administration of immunosuppressive therapy (IST) is required to avoid allograft rejection in transplant recipients. However, these therapeutic interventions can lead to significant side…
  • 2022 American Transplant Congress

    How Does Anti-CD38 Antibody Treatment (Daratumumab) Impact Immunological Assessment in Solid Organ Transplantation?

    S. Ho1, K. Putnam2, C. Peiter2, W. Herczyk2, J. Gerlach3, E. Campagnaro4, Y. Lu4, K. Woodside4, M. Cusick4

    1Gift of Hope Organ & Tissue Donor Network, Itasca, IL, 2Gift of Life Michigan, Ann Arbor, MI, 3Michigan State University, East Lansing, MI, 4University of Michigan Medicine, Ann Arbor, MI

    *Purpose: We report the first case of Dara interference of routine pre-transplant (Tx) crossmatch (XM) repeatedly causing aberrant false positives which inadvertently delayed Tx for…
  • 2022 American Transplant Congress

    Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients: Practice Patterns, Report from the Paramour “Pediatric Renal AMR Outcomes” Study

    N. Hayde1, K. Twombley2, I. Ashoor3, R. Engen4, L. Harshman5, R. Zahr6, C. Peterson7, S. McEwen8, A. Jain9, R. Garro10, M. Kallash11, A. Mansuri12, D. Puliyanda13

    1Montefiore Medical Center, Bronx, NY, 2Medical University of South Carolina, Charleston, SC, 3LCMCHealth, New Orleans, LA, 4Pediatrics, University of Wisconsin Madison, Madison, WI, 5University of Iowa Children's Hospital, Iowa City, IA, 6Le Bonheur Children's Hospital, Nashville, TN, 7University of Utah, Salt Lake City, UT, 8University of Minnesota, Minneapolis, MN, 9Wayne State, Troy, MI, 10Emory Universtiy, Atlanta, GA, 11The Ohio State, Columbus, OH, 12Augusta University Medical Center, Augusta, GA, 13Cedars-Sinai Med Ctr, West Hollywood, CA

    *Purpose: There is insufficient data on children with AMR in the literature, and the optimal therapy for AMR is not well defined. We aim to…
  • 2022 American Transplant Congress

    Implementing Clinical Decision Support Tools for Immunosuppressant Drug-Drug Interactions to Prevent Graft Failure

    A. Yishak1, S. Ledan2, S. Mukherjee3, C. Chen2, A. Ayoola2, T. Kim2, A. Olenik2, K. Mullican2, A. Henje2, N. Lorence2, L. Beckman2

    1MAPMG, Mc Lean, VA, 2Kaiser Permanente, Silver Spring, MD, 3MAPMG, Rockville, MA

    *Purpose: Immunosuppressant drug-drug interactions can result in immunosuppressant toxicity or subtherapeutic levels causing rejection. If not identified and managed appropriately, these interactions may result in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 138
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences